NCT00796666 - Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil | Biotech Hunter

Enrollment

131

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions

Pulmonary Arterial HypertensionPulmonary Hypertension

Interventions

DRUG

Sitaxsentan

Sitaxsentan = 100 mg tablet administered orally, once daily Sildenafil placebo = 1 tablet administered orally, three times a day

DRUG

Sitaxsentan and Sildenafil

Sitaxsentan = 100 mg tablet administered orally, once daily plus Sildenafil = 20 mg tablet administered orally, three times a day

Trial Locations (48)

32

Pfizer Investigational Site, Lima

1233

Pfizer Investigational Site, Sofia

2193

Pfizer Investigational Site, Johannesburg

10700

Pfizer Investigational Site, Bangkoknoi

10990

Pfizer Investigational Site, George Town

11000

Pfizer Investigational Site, Belgrade

27599

Pfizer Investigational Site, Chapel Hill

32610

Pfizer Investigational Site, Gainesville

33331

Pfizer Investigational Site, Weston

34080

Pfizer Investigational Site, Istanbul, Fatih

44106

Pfizer Investigational Site, Cleveland

45219

Pfizer Investigational Site, Cincinnati

53215

Pfizer Investigational Site, Milwaukee

64718

Pfizer Investigational Site, Monterrey

68131

Pfizer Investigational Site, Omaha

77030

Pfizer Investigational Site, Houston

78229

Pfizer Investigational Site, San Antonio

92708

Pfizer Investigational Site, Fountain Valley

100032

Pfizer Investigational Site, Beijing

105077

Pfizer Investigational Site, Moscow

194156

Pfizer Investigational Site, Moscow

197022

Pfizer Investigational Site, Saint Petersburg

197341

Pfizer Investigational Site, Saint Petersburg

200001

Pfizer Investigational Site, Shanghai

200433

Pfizer Investigational Site, Shanghai

410008

Pfizer Investigational Site, Changsha

4781173

Pfizer Investigational Site, Temuco

02111

Pfizer Investigational Site, Boston

02903

Pfizer Investigational Site, Providence

C1039AAO

Pfizer Investigational Site, Buenos Aires

C1428DCO

Pfizer Investigational Site, Buenos Aires

C1428DUS

Pfizer Investigational Site, Buenos Aires

C1431FWO

Pfizer Investigational Site, Buenos Aires

Unknown

Pfizer Investigational Site, Bogotá

Pfizer Investigational Site, Kyiv

128 08

Pfizer Investigational Site, Prague

500 001

Pfizer Investigational Site, Hyderabad

500 063

Pfizer Investigational Site, Hyderabad

380 015

Pfizer Investigational Site, Ahmedabad

380 060

Pfizer Investigational Site, Ahmedabad

395 007

Pfizer Investigational Site, Surat

390 015

Pfizer Investigational Site, Vadodara

411 030

Pfizer Investigational Site, Pune

641 014

Pfizer Investigational Site, Coimbatore

625 107

Pfizer Investigational Site, Madurai

400 001

Pfizer Investigational Site, Cluj-Napoca

700 503

Pfizer Investigational Site, Iași

03680

Pfizer Investigational Site, Kyiv